Search results
Live from ASCO 2024 | Ascentage Pharma Releases Updated Data of FAK/ALK/ROS1 Inhibitor APG-2449 in...
Benzinga· 6 days agoSUZHOU, China, and ROCKVILLE, Md., June 1, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related
New drug shows promise in easing chronic pain, study finds
Medical Xpress· 5 days agoChronic pain afflicts millions of people, but for many, a reliable, nonaddictive drug to ease their suffering remains out of reach. In their most recent study, published in ...
Apple AI Push, Fed, Tesla In Focus; How To Handle This Rally
Investor's Business Daily· 11 hours agoAn Eli Lilly Alzheimer's drug and three big earnings loom.
Days after Trump's guilty verdict, Hunter Biden heads to court
NBC News via Yahoo News· 6 days agoThree days after Joe Biden proclaimed that “no one is above the law,” his lone surviving son,...
Eli Lilly adds ALS drug prospect with QurAlis deal
BioPharma Dive via Yahoo Finance· 5 days agoThe alliance hands Lilly an RNA-based therapy in preclinical testing for ALS and frontotemporal dementia, and includes a research collaboration to...
With a drop of blood, this new device will test for TBIs in 15 minutes
Military Times via Yahoo News· 4 days agoA new rapid test that checks for traumatic brain injuries using a single drop of blood is expected...
Greater focus on crime sparks another wave of juvenile justice bills
Maine Morning Star via Yahoo News· 24 hours agoFor decades, state legislators and criminal justice advocates have worked to change the juvenile...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 7 days agoResults from Phase 1 dose escalation trial of BDTX-1535 in GBM patients demonstrated a favorable safety and tolerability profile, and encouraging anti-tumor activity and duration of treatment Initial data from Phase 0/1 “trigger” (“window of
Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate Update - Addex...
Benzinga· 2 days ago● GABAB PAM: Selection of drug candidates under Indivior collaboration expected by end of Q2 2024. Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 6, 2024 - Addex Therapeutics
Prenatal supplements fall woefully short in providing crucial nutrition during pregnancy – and most...
San Francisco Chronicle· 4 days agoThere are no rules that require these supplements to contain any nutrients at all, let alone the appropriate doses. Not surprisingly, research shows that none of the most widely available over-the-counter ...